Mammographic density changes during neoadjuvant breast cancer treatment: NeoDense, a prospective study in Sweden

Objectives: To assess if mammographic density (MD) changes during neoadjuvant breast cancer treatment and is predictive of a pathological complete response (pCR). Methods: We prospectively included 200 breast cancer patients assigned to neoadjuvant chemotherapy (NACT) in the NeoDense study (2014–201...

Full description

Bibliographic Details
Main Authors: Ida Skarping, Daniel Förnvik, Uffe Heide-Jørgensen, Hanna Sartor, Per Hall, Sophia Zackrisson, Signe Borgquist
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:Breast
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S096097762030120X